Skip to content

SI-BONE, Inc. SIBN Payments Of Financing Fee, Final

Payments Of Financing Fee, Final at other companies

Trex Company logo
Trex CompanyTREX
$2.44M+24,480%
KRT
Karat PackagingKRT
$11K-76.6%
Lithium Americas logo
Lithium AmericasLAC
$832K-91.0%
AMN Healthcare logo
AMN HealthcareAMN
$5K
Century Communities logo
Century CommunitiesCCS
$0-100%
PRA Group logo
PRA GroupPRAA
$30K-96.6%

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept sibn:PaymentsOfFinancingFeeFinal.

The official record: SI-BONE, Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s payments of financing fee, final.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s payments of financing fee, final?
SI-BONE, Inc. (SIBN) reported payments of financing fee, final of $0 in Q4 2025.
How has SI-BONE, Inc.'s payments of financing fee, final changed year-over-year?
SI-BONE, Inc.'s payments of financing fee, final decreased by 100.0% year-over-year, from $180K to $0.
What does payments of financing fee, final mean?
This metric captures the cash outflows associated with fees paid to lenders, underwriters, or other financial institutions to secure debt or equity financing. It reflects the direct cost of capital acquisition and is distinct from periodic interest payments. Monitoring these payments helps investors assess the cost-efficiency of the company's capital structure and financing activities.